|
Nov 22,2022 05:01 pm - Tuesday
FDA unveils hybrid back-to-office policyNov 18,2022 05:02 pm - Friday
House Covid oversight panel’s fate on the lineNov 15,2022 05:01 pm - Tuesday
Despite Senate loss, GOP will focus on oversightNov 11,2022 05:02 pm - Friday
Congress expected to take up leftover FDA bills in lame duckNov 08,2022 05:01 pm - Tuesday
Lame-duck, new Congress face pharma reformsNov 04,2022 04:01 pm - Friday
New boosters dramatically increase antibodiesNov 01,2022 04:01 pm - Tuesday
Califf: Potential benefits of Twitter exceed risks